Esther H Lips

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. doi request reprint Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
    Esther H Lips
    Department of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 136:35-43. 2012
  2. pmc Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
    Esther H Lips
    Department of Experimental Therapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res 13:R107. 2011
  3. doi request reprint SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
    Jorma J de Ronde
    Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 137:213-23. 2013
  4. doi request reprint Platform comparisons for identification of breast cancers with a BRCA-like copy number profile
    Philip C Schouten
    Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 139:317-27. 2013

Collaborators

Detail Information

Publications4

  1. doi request reprint Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer
    Esther H Lips
    Department of Experimental Therapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 136:35-43. 2012
    ..However, this difference is explained by differences in molecular characteristics, particularly HR and HER2, and independent of lobular histology...
  2. pmc Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
    Esther H Lips
    Department of Experimental Therapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res 13:R107. 2011
    ....
  3. doi request reprint SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
    Jorma J de Ronde
    Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 137:213-23. 2013
    ....
  4. doi request reprint Platform comparisons for identification of breast cancers with a BRCA-like copy number profile
    Philip C Schouten
    Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 139:317-27. 2013
    ..Our findings suggest that it is possible to map copy number data from any other technology in a similar way...